# clm_9690B63B18DE

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 1,344,900,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-04-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_521AF355924A  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 1,344,900,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_9690B63B18DE, https://asof.is/claim/clm_9690B63B18DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/0000059478-23-000162-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-04-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/0000059478-23-000162-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-04-27)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 1,451,700,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_9690B63B18DE](/claim/clm_9690B63B18DE.md) | [clm_2B253B0B594C](/claim/clm_2B253B0B594C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.